Commercial Activist investor renews its criticism of Novavax PharmaphorumShah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."CommercialRead full story pharminent April 8, 2026 (Last updated: April 8, 2026) Pharmaphorum Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a “destruction in shareholder value.” CommercialRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make HeadwayNext: Sidewinder pockets $137m in Series B to take bispecific ADCs to clinic Related Stories Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026 Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026 Commercial Lilly launches its LillyDirect sales channel in the UK pharminent June 25, 2026
